These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37424832)

  • 21. Effects of intravenous dantrolene sodium on respiratory and cardiovascular functions.
    Ellis KO; Wessels FL; Carpenter JF
    J Pharm Sci; 1976 Sep; 65(9):1359-64. PubMed ID: 966155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
    Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
    Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.
    Britt BA; Scott E; Frodis W; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1984 Mar; 31(2):130-54. PubMed ID: 6704779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in predicted values from near-infrared spectra of samples in vials by using a calibration model developed from spectra of samples in vials: causes of the variations and compensation methods.
    Watari M; Du Y; Ozaki Y
    Appl Spectrosc; 2007 Apr; 61(4):397-405. PubMed ID: 17456258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.
    Chen M; Wu Q; Jiang J; Jin X; Liu S; Wang M; Zhao C
    J Pharm Biomed Anal; 2017 Feb; 135():153-159. PubMed ID: 28027523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dantrolene sodium on contractility of isolated human uterine muscle.
    Shin YK; Kim YD; Collea JV; Belcher MD
    Int J Obstet Anesth; 1995 Oct; 4(4):197-200. PubMed ID: 15637010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors.
    Fruen BR; Mickelson JR; Louis CF
    J Biol Chem; 1997 Oct; 272(43):26965-71. PubMed ID: 9341133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.
    Palnitkar SS; Mickelson JR; Louis CF; Parness J
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):847-52. PubMed ID: 9307036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dantrolene sodium on rat skeletal muscle in relation to the plasma concentration.
    Meyler WJ; Mols-Thurkow I; Scaf AH; Sargo S; Wesseling H
    Eur J Pharmacol; 1979 Feb; 53(4):335-42. PubMed ID: 421731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of skeletal, cardiac, and smooth muscle actions of dantrolene sodium--a skeletal muscle relaxant.
    Ellis KO; Butterfield JL; Wessels FL; Carpenter JF
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):118-32. PubMed ID: 1015907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
    Nelson TE; Lin M; Zapata-Sudo G; Sudo RT
    Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).
    Flewellen EH; Nelson TE; Bee DE
    Can Anaesth Soc J; 1980 Jan; 27(1):16-21. PubMed ID: 7353186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stocks of dantrolene in anesthesia and intensive care units in Germany : Nationwide online survey with 1673 participants].
    Pfenninger E; Heiderich S; Klingler W
    Anaesthesist; 2017 Oct; 66(10):773-781. PubMed ID: 28660414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia.
    Lopez JR; Gerardi A; Lopez MJ; Allen PD
    Anesthesiology; 1992 May; 76(5):711-9. PubMed ID: 1575338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle relaxant action of dantrolene sodium in rats.
    Saito S; Harada M; Yamamoto M; Takagi H; Saito K; Konno Y
    Res Commun Chem Pathol Pharmacol; 1993 Sep; 81(3):345-54. PubMed ID: 8235068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.